Clinical Trials Logo

Overweight clinical trials

View clinical trials related to Overweight.

Filter by:

NCT ID: NCT03927534 Completed - Clinical trials for Overweight and Obesity

Efficacy of a Mindful-eating Program to Reduce Emotional Eating

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

Mindfulness-Based Interventions have been applied in different fields to improve physical and psychological health. However, little is known about its applicability and effectiveness in Spanish adults with overweight and obesity. The aim of the present study protocol is to evaluate the feasibility and efficacy of an adapted MBI programme to reduce emotional eating in adults with overweight and obesity in primary care (PC) settings.

NCT ID: NCT03922945 Completed - Adolescent Obesity Clinical Trials

A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With Obesity

Start date: May 2, 2019
Phase: Phase 4
Study type: Interventional

This study is being conducted to assess weight loss efficacy, as determined by changes in body mass index (BMI), and safety of VI-0521 (Qsymia®) or placebo, taken for 56 weeks accompanied by a lifestyle modification program in obese adolescents age 12-16 years.

NCT ID: NCT03921580 Completed - Overweight Clinical Trials

Enriched Canned Tuna With Fibre or Polyphenols on Satiety

SACIATUN
Start date: June 22, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the satiating effects of different canned tuna preserved in olive oil enriched with soluble fiber or polyphenols on overweight subjects (BMI ≥25 and <30 kg / m2). Some studies have shown the contribution of high-fiber foods in the reduction of the cardiovascular risk.

NCT ID: NCT03918005 Not yet recruiting - Obesity Clinical Trials

Effects of Hypocaloric Diets With Different Glycemic Loads on Pulse Wave Velocity

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

Worldwide, in terms of attributable deaths, the main intermediate risk factor for the development of cardiovascular diseases is systemic arterial hypertension, followed by overweight and sustained hyperglycemia. These factors have positively influenced public and private spending on health. The more robust studies showed that age is one of the main determinants of arterial stiffness. However, there is a possibility that other variables, such as elevated glucose levels, obesity, and systemic inflammation itself, as well as insulin resistance are important factors in this scenario. On the other hand, the measurement of the pulse wave velocity is widely acceptable for the evaluation of the arterial stiffness, inferring the cardiovascular risk in different populations. Since arterial stiffness is influenced by hemodynamic forces and inflammatory mediators, which may be related to sodium and glucose balance, it is necessary to evaluate whether a hypocaloric and low glycemic load diet, in a thesis that decreases lipid and inflammatory levels, may have favorable effects on pulse wave velocity in overweight adults.

NCT ID: NCT03914508 Completed - Obesity Clinical Trials

PACIFIC-FIT: Providing Adults Collaborative Interventions for Ideal Changes Focused Intervention and Tracking

Start date: June 28, 2019
Phase: N/A
Study type: Interventional

The pilot study will be a one group treatment program and will be utilized to refine the M+BWL program.

NCT ID: NCT03914066 Terminated - Clinical trials for Overweight and Obesity

A Group-based Treatment of Overweight and Obesity in Primary Care

Start date: September 3, 2019
Phase: N/A
Study type: Interventional

Overweight and obesity is a growing problem in the world. Today more than 50 % of all people over 18 years in Sweden are overweight or obese. Main reasons for this are changes in lifestyle habits regarding diet and physical exercise. Overweight and obesity increases risk of different diseases such as type 2 diabetes, arthrosis and cancer; it also affects quality of life. Losing 5-10 % of your body weight improves metabolic health and quality of life. Lifestyle changes are very important in order to lose weight but it can be challenging to carry through with these changes on your own without support. In the primary care in Region Orebro län a group treatment, "Step by step", has been in use since 2010. It comprises of six group sessions over 6-8 months with different themes such as diet, physical exercise and stress. Between the group sessions there are home assignments, such as writing a diet or exercise diary. This observational study will evaluate "Step by step" and the effect the group treatment has on the participants' weight, dietary habits, physical activity, quality of life, eating habits and metabolic health.

NCT ID: NCT03912922 Completed - Clinical trials for Overweight and Obesity

SIT LESS 4: How Does Reducing Sitting Time Improve Glucose and Lipid Metabolism?

SITLESS4
Start date: December 15, 2017
Phase: N/A
Study type: Interventional

Research has shown that replacing sitting time with low intensity physical activity (such as slowly walking and standing) has beneficial effects on metabolic health, like insulin sensitivity, comparable to improvements after sitting all day in combination with 1h streneous exercise. The main objective of this study is to investigate the underlying mechanisms responsible for improved insulin sensitivity after 4 days of sitting less compared to sitting and exercise in healthy obese women. Our secondary objective is to investigate the effects of sitting less on cardio metabolic parameters.

NCT ID: NCT03911583 Active, not recruiting - Obesity Clinical Trials

Effectiveness of PUSH Notifications From a Mobile App for Improving the Body Composition of Overweight or Obese Women

Start date: January 1, 2016
Phase: N/A
Study type: Interventional

A clinical three-armed assay has been established to permit an evaluation of the effectiveness of implementing PUSH notifications in the actions orientated towards improving body composition through the establishment of dietary patterns and an increase in physical activity.

NCT ID: NCT03908996 Completed - Overweight Clinical Trials

the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer

Start date: February 11, 2019
Phase: N/A
Study type: Interventional

The primary purpose of this study is to evaluate the effectiveness of a 12-month comprehensive weight management program on weight change in overweight/obese patients following treatment for endometrial cancer. During the study period, subjects will be monitored for recurrence during routine clinic visits A secondary exploratory purpose of this study will be to evaluate the gut microbiome in this intervention group and the changes that may occur while participating in a weight loss and weight management program.

NCT ID: NCT03908216 Completed - Clinical trials for Overweight and Obesity

Evaluation of Non-pharmacological and Pharmacological Treatment for oVerweight and Obesity in pAtients of the Outpatient Register (EVA)

EVA
Start date: April 18, 2019
Phase:
Study type: Observational

A prospective non-interventional single-centre study aimed to assess the current practice of non-pharmacological treatment and pharmacological therapy of overweight and obesity in patients with cardiovascular diseases (CVD) or with a high risk of CVD according to the patients' survey data